Literature DB >> 9723941

Influence of chronic hypoxia on the contributions of non-inactivating and delayed rectifier K currents to the resting potential and tone of rat pulmonary artery smooth muscle.

O N Osipenko1, D Alexander, M R MacLean, A M Gurney.   

Abstract

Exposing rats to chronic hypoxia increased the 4-aminopyridine (4-AP) sensitivity of pulmonary arteries. 1 mM 4-AP caused smooth muscle cell depolarization and contraction in arteries from hypoxic rats, but had little effect in age-matched controls. Chronic hypoxia downregulated delayed rectifier K+ current (IK(V)), which was nearly 50% blocked by 1 mM 4-AP, and non-inactivating K+ current (IK(N)), which was little affected by 1 mM 4-AP. The results suggest that IK(N) determines resting potential in control rats and that its downregulation following hypoxia leads to depolarization, which activates IK(V) and increases its contribution to resting potential. The hypoxia-induced increase in 4-AP sensitivity thus reflects a switch in the major K+ current determining resting potential, from IK(N) to IK(V). This has important implications for the actions and specificity of pulmonary vasodilator drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723941      PMCID: PMC1565551          DOI: 10.1038/sj.bjp.0702006

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

Review 1.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Acute oxygen-sensing mechanisms.

Authors:  E Kenneth Weir; José López-Barneo; Keith J Buckler; Stephen L Archer
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

3.  Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries.

Authors:  Sergey V Smirnov; Richard Beck; Paolo Tammaro; Tetsuro Ishii; Philip I Aaronson
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

4.  Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat.

Authors:  J P Dumas; F Goirand; M Bardou; M Dumas; L Rochette; C Advenier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Hypoxia induces voltage-gated K+ (Kv) channel expression in pulmonary arterial smooth muscle cells through hypoxia-inducible factor-1 (HIF-1).

Authors:  Qian Dong; Ning Zhao; Cheng-Kun Xia; Li-li Du; Xiao-Xing Fu; Yi-Mei Du
Journal:  Bosn J Basic Med Sci       Date:  2012-08       Impact factor: 3.363

6.  Decreased expression of voltage-gated K+ channels in pulmonary artery smooth muscles cells in nitrofen-induced congenital diaphragmatic hernia in rats.

Authors:  Masato Sakai; Kei Unemoto; Valeria Solari; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-04-15       Impact factor: 1.827

7.  Organ culture mimics the effects of hypoxia on membrane potential, K(+) channels and vessel tone in pulmonary artery.

Authors:  Boris Manoury; Sarah L Etheridge; Joy Reid; Alison M Gurney
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

8.  Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.

Authors:  I Morecroft; A Murray; M Nilsen; A M Gurney; M R MacLean
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

9.  Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries.

Authors:  M J Gardener; I T Johnson; M P Burnham; G Edwards; A M Heagerty; A H Weston
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

Review 10.  Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus.

Authors:  E K Weir; M Obreztchikova; A Vargese; J A Cabrera; D A Peterson; Z Hong
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.